All the news Showing 5 of 45 articles from: Diagnosis and monitoringGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C Michael Carter / 13 June 2012 Doctors in Europe and the US have conflicting opinions about the pace of liver fibrosis in HIV-positive men with hepatitis C infection. In a study published in Clinical Infectious Diseases, European investigators ... Hepatitis C testing rate low and knowledge of the infection poor in the US "baby boomer" generation Michael Carter / 18 May 2012 Only a quarter of US individuals in the generation most likely to have hepatitis C have ever been tested for the infection, results of a survey conducted by the American Gastroenterological Association (AGA) ... Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity Liz Highleyman / 30 April 2012 The experimental cancer drug brivanib did not lengthen overall survival for patients with hepatocellular carcinoma, but it did increase time to progression, demonstrating that it had anti-tumour activity, researchers reported at the 47th ... Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy Michael Carter / 04 November 2011 The persistence of a low viral load during the first twelve weeks of hepatitis C therapy is associated with an increased risk of relapse after the completion of treatment, investigators report in ... Some rapid hepatitis C tests have high false-negative rate in people with HIV Michael Carter / 22 August 2011 Approximately 9% of hepatitis C infections in HIV-positive individuals are missed by some rapid hepatitis C testing assays, US investigators report in the September 15th edition of the Journal of Infectious Diseases. Three ... ← Prev12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive